🌍·13h agoResearch
Randomized phase 2 trial of CPX-351 vs. CLAG-M (cladribine, cytarabine, G-CSF, and mitoxantrone) for medically unfit adults with acute myeloid leukemia or other high-grade myeloid neoplasms
Publisher
C
Crossref
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Crossref
- Region
- Global
- Scope
- Research
- Published
- July 13, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on doi.org
Leave the platform to read the original full article on the publisher site.
Source: Crossref
Scope: Research
Related coverage
More related coverage
Universitätsklinikum Heidelberg/4h ago
Universitätsklinikum Mannheim: Richtfest für neues Institutsgebäude
UNMC/6h ago
A message from President Gold on recent state budget directives
Hospital Clínic de Barcelona/6h ago
What are the new drugs and why are they a concern?
Policlinico di Milano/6h ago